Clinical trial
IMPAACT P1073: Study Of Immune Reconstitution Inflammatory Syndrome (IRIS) For International Sites Initiating Highly Active Antiretroviral Therapy (HAART) In Infants And Children < 72 Months Of Age
NCT01240486 is registered in ClinicalTrials.gov with International Maternal Pediatric Adolescent AIDS Clinical Trials Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- IMPAACT P1073: Study Of Immune Reconstitution Inflammatory Syndrome (IRIS) For International Sites Initiating Highly Active Antiretroviral Therapy (HAART) In Infants And Children < 72 Months Of Age
- Lead sponsor
- International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2010
- Completion date
- October 31, 2013
- Enrollment
- 207 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
hiv, iris